These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24270109)

  • 1. Indeterminate liver and renal lesions: comparison of computed tomography and magnetic resonance imaging in providing a definitive diagnosis and impact on recommendations for additional imaging.
    Margolis NE; Shaver CM; Rosenkrantz AB
    J Comput Assist Tomogr; 2013; 37(6):882-6. PubMed ID: 24270109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of biphasic spiral CT, conventional and iron oxide enhanced MRI on therapy and therapy costs in patients with focal liver lesions].
    Helmberger T; Gregor M; Holzknecht N; Rau H; Scheidler J; Reiser M
    Rofo; 2000 Mar; 172(3):251-9. PubMed ID: 10778456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
    Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
    J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is ultrasound imaging inferior to computed tomography or magnetic resonance imaging in evaluating renal mass size?
    Mucksavage P; Ramchandani P; Malkowicz SB; Guzzo TJ
    Urology; 2012 Jan; 79(1):28-31. PubMed ID: 22202542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Contrast-Enhanced Multiphase Renal Protocol CT Versus MRI for Diagnosis of Papillary Renal Cell Carcinoma.
    Dilauro M; Quon M; McInnes MD; Vakili M; Chung A; Flood TA; Schieda N
    AJR Am J Roentgenol; 2016 Feb; 206(2):319-25. PubMed ID: 26797358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of MRI in the Characterization of Indeterminate Small Renal Lesions Previously Seen on Screening CT Scans of Potential Renal Donor Patients.
    Fananapazir G; Lamba R; Lewis B; Corwin MT; Naderi S; Troppmann C
    AJR Am J Roentgenol; 2015 Aug; 205(2):325-30. PubMed ID: 26204282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The costs and utility of imaging in evaluating dizzy patients in the emergency room.
    Ahsan SF; Syamal MN; Yaremchuk K; Peterson E; Seidman M
    Laryngoscope; 2013 Sep; 123(9):2250-3. PubMed ID: 23821602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.
    Sangiovanni A; Manini MA; Iavarone M; Romeo R; Forzenigo LV; Fraquelli M; Massironi S; Della Corte C; Ronchi G; Rumi MG; Biondetti P; Colombo M
    Gut; 2010 May; 59(5):638-44. PubMed ID: 19951909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements.
    Becker-Weidman DJ; Kalb B; Sharma P; Kitajima HD; Lurie CR; Chen Z; Spivey JR; Knechtle SJ; Hanish SI; Adsay NV; Farris AB; Martin DR
    Radiology; 2011 Dec; 261(3):824-33. PubMed ID: 21969663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.
    Dromain C; de Baere T; Lumbroso J; Caillet H; Laplanche A; Boige V; Ducreux M; Duvillard P; Elias D; Schlumberger M; Sigal R; Baudin E
    J Clin Oncol; 2005 Jan; 23(1):70-8. PubMed ID: 15625361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs in follow-up of endovascularly repaired abdominal aortic aneurysms. Magnetic resonance imaging with MR angiography versus EUROSTAR protocols.
    Engellau L; Albrechtsson U; Höjgård S; Norgren L; Larsson EM
    Int Angiol; 2003 Mar; 22(1):36-42. PubMed ID: 12771854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suspicious breast lesions detected at 3.0 T magnetic resonance imaging: clinical and histological outcomes.
    Johnson KS; Baker JA; Lee SS; Soo MS
    Acad Radiol; 2012 Jun; 19(6):667-74. PubMed ID: 22459645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical impact of magnetic resonance imaging in diagnosing focal hepatic lesions and suspected cancer.
    Shah AJ; Parsons B; Pope I; Callaway M; Finch-Jones MD; Thomas MG
    Clin Imaging; 2009; 33(3):209-12. PubMed ID: 19411027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic liver tumor from cystic ovarian carcinomas: CT and MRI appearance.
    Tang Y; Yamashita Y; Ogata I; Namimoto T; Abe Y; Urata J; Takahashi M
    Radiat Med; 1999; 17(4):265-70. PubMed ID: 10510898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging.
    Takahashi M; Maruyama H; Shimada T; Kamezaki H; Sekimoto T; Kanai F; Yokosuka O
    Eur J Radiol; 2013 Jan; 82(1):75-84. PubMed ID: 23116806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a need for MRI within 24 hours after CT-guided percutaneous thermoablation of the liver?
    Ringe KI; Wacker F; Raatschen HJ
    Acta Radiol; 2015 Jan; 56(1):10-7. PubMed ID: 24445091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Size discrepancy between sonographic and computed tomographic/magnetic resonance imaging measurement of hepatocellular carcinoma: the necessity of tumor size measurement standardization.
    Cha MJ; Lee MW; Cha DI; Kim JH; Rhim H; Cho YK; Kim YJ; Choi D; Kim YS; Lim HK
    J Ultrasound Med; 2013 Oct; 32(10):1703-9. PubMed ID: 24065250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.